How much funding has Sapyen raised?

Sapyen has raised $10.1M in total funding, most recently a Series A round.

Who are Sapyen's investors?

Sapyen's investors include Antler.

Where is Sapyen headquartered?

Sapyen is headquartered in Melbourne, Australia.

What industry is Sapyen in?

Sapyen operates in Healthcare, FemTech & Reproductive Health.

Sapyen

Lab accuracy. Home comfort.

Melbourne, Australia · Founded 2021 · $10.1M raised

Healthcare

FemTech & Reproductive Health

Headquarters: Melbourne
Employees: 11–50
Founded: 2021
Business Model: B2C

Website: sapyen.co
Total Funding: $10.1M
Last Round: $10.0M Series ANov 2021
Rounds: 2

About

Sapyen is an Australian at-home male fertility diagnostics company founded in 2021, headquartered in Melbourne. The company offers a range of clinically accurate semen analysis tests that men can perform from home, with samples analyzed by accredited IVF and diagnostic laboratories. Sapyen's proprietary stabilization fluid keeps samples viable for up to three days during transport, enabling lab-grade accuracy without a clinic visit. Its test menu includes core semen analysis, DNA fragmentation testing, antisperm antibody testing, SpermEGT DNA methylation testing, post-vasectomy analysis, and sperm cryopreservation. Trusted by leading IVF networks including IVIRMA, Ivy Fertility, and Monash IVF, Sapyen has expanded to the United Kingdom, United States, Canada, and multiple European markets.

Summary

Sapyen is a Healthcare company based in Melbourne, Australia, founded in 2021. It has raised $10.1M in total across 2 rounds, most recently a $10.0M Series A round in Nov 2021. Investors include Antler.